| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd0226bc5956444f686893e2aea57281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6727fded32b3009b6a61e17a20c8b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60654b29775771d247b40f36082a9b22 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2012-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82ba6b5b5395f0c4bf6f9743a497c893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8627cbcab2b536693a95b6f04d68ecb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8f0378ef26b2276fceb64ac9e3565db |
| publicationDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012134704-A9 |
| titleOfInvention |
Systems and methods for optogenetic modulation of cells within a patient |
| abstract |
Cells within a patient are optogenetically modulated to treat various neurological disorders. In one example, a method includes delivering a viral vector including a genetic agent encoding for one or more light-sensitive proteins to a delivery site within a patient. The viral vector includes retrograde and/or anterograde transport properties such that the viral vector is configured to transduce the genetic agent into cells at the delivery site and into cells in a plurality of sites proximal and remote to the delivery site. A bioelectrical signal(s) related to a neurological condition of the patient is sensed, e.g. using an implanted electrode. Optical stimulation is delivered to cells transduced with the genetic agent by the viral vector to treat the neurological condition of the patient. |
| priorityDate |
2011-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |